Clinical trials: Legionnaires' Disease
Legionnaires' Disease, Legionella Pneumophila Infections
Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
To collect retrospectively the efficacy and safety information of azithromycin IV on patients with Legionnaires' disease related to their appropriate use in daily practice.
- Trial name
- RESCUE-L (NCT01784770)
- Testing
- Azithromycin IV
- Volunteers
- 21 people
- Sponsor
- Pfizer